Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

Effect of rosuvastatin on repeat heart failure hospitalizations: the corona trial (controlled rosuvastatin multinational trial in heart failure)

<p style="text-align:justify;"> <b>Objectives:</b> This study sought to examine the effect of statin therapy hospitalizations for heart failure (HFH) in patients in the CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure) trial.<br/><br/> <...

Bibliografiset tiedot
Päätekijät:	Rogers, J, Jhund, P, Perez, A, Böhm, M, Cleland, J, Gullestad, L, Kjekshus, J, Van Veldhuisen, D, Wikstrand, J, Wedel, H, McMurray, J, Pocock, S
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2014

Samankaltaisia teoksia

Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Tekijä: Erik Tandberg Askevold, et al.
Julkaistu: (2015-01-01)

Rosuvastatin in older patients with systolic heart failure.
Tekijä: Florkowski, C, et al.
Julkaistu: (2008)

Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis
Tekijä: Kotecha, D, et al.
Julkaistu: (2017)

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials
Tekijä: Cleland, J, et al.
Julkaistu: (2017)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
Tekijä: Gounari, P, et al.
Julkaistu: (2010)

Rosuvastatin safety and efficacy in coronary heart disease patients
Tekijä: I. V. Sergienko, et al.
Julkaistu: (2006-10-01)

Eplerenone in patients with systolic heart failure and mild symptoms
Tekijä: Rogers, J, et al.
Julkaistu: (2012)

Acute renal failure due to rhabdomyolysis in relation to abiraterone and rosuvastatin
Tekijä: Melissa Cintra, et al.
Julkaistu: (2023-05-01)

Comparative effects of rosuvastatin and allopurinol on circulating levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with chronic heart failure.
Tekijä: Tousoulis, D, et al.
Julkaistu: (2010)

Perioperative rosuvastatin in cardiac surgery
Tekijä: Zheng, Z, et al.
Julkaistu: (2016)

Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products
Tekijä: Jure Zakrajšek, et al.
Julkaistu: (2017-12-01)

The Antimycotic Activity of Rosuvastatin
Tekijä: Zahraa Qasim
Julkaistu: (2022-12-01)

Current perspectives on rosuvastatin
Tekijä: Hu M, et al.
Julkaistu: (2013-04-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
Tekijä: S. R. Gilyarevsky
Julkaistu: (2015-12-01)

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?
Tekijä: S. R. Gilyarevsky
Julkaistu: (2015-12-01)

Rosuvastatin-Induced reversible rhabdomyolysis
Tekijä: Sangeeta Pradhan, et al.
Julkaistu: (2023-01-01)

Rosuvastatin induced photolocalized purpura
Tekijä: Marwa Thabouti, et al.
Julkaistu: (2022-09-01)

Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
Tekijä: Sang-Hyeon Ju, et al.
Julkaistu: (2024-03-01)

The JUPITER and AURORA clinical trials for rosuvastatin in special primary prevention populations: perspectives, outcomes, and consequences
Tekijä: Venkata Narla, et al.
Julkaistu: (2009-11-01)

The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.
Tekijä: Kaspar Broch, et al.
Julkaistu: (2014-01-01)

The year in cardiology: heart failure. The year in cardiology 2019
Tekijä: J.G.F. Cleland, et al.
Julkaistu: (2020-04-01)

THE CONCERNS OF ROSUVASTATIN CLINICAL EFFICACY AND SAFETY
Tekijä: V. V. Kukharchuk, et al.
Julkaistu: (2013-06-01)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
Tekijä: Lijun Wang, et al.
Julkaistu: (2018-06-01)

Reducing cardiovascular risk: an emphasis on rosuvastatin
Tekijä: Anikin G.S., et al.
Julkaistu: (2017-11-01)

Analysis of genetic aspects of therapy with Rosuvastatin
Tekijä: Samat Kozhakhmetov, et al.
Julkaistu: (2016-06-01)

Preparation and optimization of microemulsion of rosuvastatin calcium
Tekijä: B Zalak Patel, et al.
Julkaistu: (2012-01-01)

Efficacy and safety of rosuvastatin in the management of dyslipidemia
Tekijä: Paolo Rubba, et al.
Julkaistu: (2009-04-01)

Debate: Statins should be used in patients with heart failure
Tekijä: Kjekshus John
Julkaistu: (2001-11-01)

Efficacy of Combination Therapy of Rosuvastatin and Ezetimibe vs Rosuvastatin Monotherapy on Lipid Profile of Patients with Coronary Artery Disease
Tekijä: Sandeep Joshi, et al.
Julkaistu: (2017-12-01)

Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales
Tekijä: Emdin, C, et al.
Julkaistu: (2016)

Clinical and echocardiographic characteristics and cardiovascular outcomes according to diabetes status in patients with heart failure and preserved ejection fraction. A report from the Irbesartan in Heart Failure with Preserved Ejection Fraction trial (I-Preserve)
Tekijä: Kristensen, S, et al.
Julkaistu: (2017)

Rethinking heart failure clinical trials: the heart failure collaboratory
Tekijä: Mutaz Alkalbani, et al.
Julkaistu: (2024-01-01)

P5.04 EFFECT OF ROSUVASTATIN ON THE ECHOLUCENCY OF THE COMMON CAROTID INTIMA–MEDIA THICKNESS: THE METEOR TRIAL
Tekijä: L. Lind, et al.
Julkaistu: (2011-11-01)

Characteristics of heart failure managed in primary care in Europe: the IMPROVEMENT of heart failure survey
Tekijä: Cleland, J, et al.
Julkaistu: (2001)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Tekijä: Dickstein, K, et al.
Julkaistu: (2010)

2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.
Tekijä: Dickstein, K, et al.
Julkaistu: (2010)

Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis
Tekijä: Kotecha, D, et al.
Julkaistu: (2016)

Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS
Tekijä: Shi Zhang, et al.
Julkaistu: (2020-11-01)

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM‐Preserved
Tekijä: Rogers, J, et al.
Julkaistu: (2013)

Perioperative rosuvastatin in cardiac surgery - Author's reply
Tekijä: Casadei, B, et al.
Julkaistu: (2016)